{"id":821342,"date":"2025-03-04T08:58:20","date_gmt":"2025-03-04T13:58:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"},"modified":"2025-03-04T08:58:20","modified_gmt":"2025-03-04T13:58:20","slug":"syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","title":{"rendered":"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>Conference call will be held on <span class=\"xn-chron\">Tuesday, March 11<\/span> at <span class=\"xn-chron\">9:00 a.m. ET<\/span><\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">CARMEL, Ind.<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 4, 2025<\/span><\/span> \/PRNewswire\/ &#8212; Syra Health Corp. (NASDAQ: SYRA), (&#8220;Syra Health&#8221; or the &#8220;Company&#8221;), a healthcare technology\u00a0company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for its fourth quarter and full year 2024 ended <span class=\"xn-chron\">December 31, 2024<\/span>, on <span class=\"xn-chron\">Tuesday, March 11, 2025<\/span>, before the market opens. The company will host a conference call that same day, <span class=\"xn-chron\">March 11, 2025<\/span>, at <span class=\"xn-chron\">9:00 a.m. ET<\/span>, to discuss the results.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.jpg\" title=\"Syra Health - A catalyst for improving health outcomes. (PRNewsfoto\/Syra Health)\" alt=\"Syra Health - A catalyst for improving health outcomes. (PRNewsfoto\/Syra Health)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Interested parties can access the conference call via webcast, available in the investors section of the company&#8217;s website at\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4374892-1&amp;h=2642947224&amp;u=https%3A%2F%2Fir.syrahealth.com%2Fpresentations%2Fq4-and-full-year-2024-earnings-call&amp;a=https%3A%2F%2Fir.syrahealth.com%2Fpresentations%2Fq4-and-full-year-2024-earnings-call\" target=\"_blank\" rel=\"nofollow\">https:\/\/ir.syrahealth.com\/presentations\/q4-and-full-year-2024-earnings-call<\/a>.<\/p>\n<p>Investors who would like to submit a question to be addressed on the call should email <a href=\"mailto:corbin@haydenir.com\" target=\"_blank\" rel=\"nofollow\">corbin@haydenir.com<\/a>.<\/p>\n<p>A webcast replay will be available in the investors section of the company&#8217;s website at<a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4374892-1&amp;h=2664439598&amp;u=https%3A%2F%2Fir.syrahealth.com%2Fpresentations%2Fq4-and-full-year-2024-earnings-call&amp;a=%C2%A0https%3A%2F%2Fir.syrahealth.com%2Fpresentations%2Fq4-and-full-year-2024-earnings-call\" target=\"_blank\" rel=\"nofollow\">\u00a0https:\/\/ir.syrahealth.com\/presentations\/q4-and-full-year-2024-earnings-call<\/a>.<\/p>\n<p>\n        <b>About Syra Health<\/b>\n      <\/p>\n<p>Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company&#8217;s leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4374892-1&amp;h=2116775800&amp;u=https%3A%2F%2Fwww.syrahealth.com%2F&amp;a=www.syrahealth.com\" target=\"_blank\" rel=\"nofollow\">www.syrahealth.com<\/a>.<\/p>\n<p>\n        <b>Contacts<\/b>\n      <\/p>\n<p>For Investor Inquiries:<br \/><span class=\"xn-person\">Corbin Woodhull<\/span><br \/>Managing Director, Global Advisory<br \/>Hayden IR<br \/>602-476-1821<br \/><a href=\"mailto:corbin@haydenir.com\" target=\"_blank\" rel=\"nofollow\">corbin@haydenir.com<\/a><\/p>\n<p>For Media Inquiries:<br \/><span class=\"xn-person\">Christine Drury<\/span><br \/>Director of Corporate Communications<br \/>Syra Health<br \/>463-345-5180<br \/><a href=\"mailto:christined@syrahealth.com\" target=\"_blank\" rel=\"nofollow\">christined@syrahealth.com<\/a><\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=DE32315&amp;sd=2025-03-04\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results-302390799.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results-302390799.html<\/a><\/p>\n<p>SOURCE  Syra Health<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DE32315&amp;Transmission_Id=202503040855PR_NEWS_USPR_____DE32315&amp;DateId=20250304\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind. , March 4, 2025 \/PRNewswire\/ &#8212; Syra Health Corp. (NASDAQ: SYRA), (&#8220;Syra Health&#8221; or the &#8220;Company&#8221;), a healthcare technology\u00a0company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for its fourth quarter and full year 2024 ended December 31, 2024, on Tuesday, March 11, 2025, before the market opens. The company will host a conference call that same day, March 11, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the conference call via webcast, available in the investors section of the company&#8217;s website at\u00a0https:\/\/ir.syrahealth.com\/presentations\/q4-and-full-year-2024-earnings-call. Investors who would like &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-821342","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind. , March 4, 2025 \/PRNewswire\/ &#8212; Syra Health Corp. (NASDAQ: SYRA), (&#8220;Syra Health&#8221; or the &#8220;Company&#8221;), a healthcare technology\u00a0company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for its fourth quarter and full year 2024 ended December 31, 2024, on Tuesday, March 11, 2025, before the market opens. The company will host a conference call that same day, March 11, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the conference call via webcast, available in the investors section of the company&#8217;s website at\u00a0https:\/\/ir.syrahealth.com\/presentations\/q4-and-full-year-2024-earnings-call. Investors who would like &hellip; Continue reading &quot;Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T13:58:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results\",\"datePublished\":\"2025-03-04T13:58:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\"},\"wordCount\":282,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1834874\\\/Syra_Health_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\",\"name\":\"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1834874\\\/Syra_Health_Logo.jpg\",\"datePublished\":\"2025-03-04T13:58:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1834874\\\/Syra_Health_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1834874\\\/Syra_Health_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk","og_description":"PR Newswire Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind. , March 4, 2025 \/PRNewswire\/ &#8212; Syra Health Corp. (NASDAQ: SYRA), (&#8220;Syra Health&#8221; or the &#8220;Company&#8221;), a healthcare technology\u00a0company dedicated to powering better health through innovative technology products and services, announced today that it will report financial results for its fourth quarter and full year 2024 ended December 31, 2024, on Tuesday, March 11, 2025, before the market opens. The company will host a conference call that same day, March 11, 2025, at 9:00 a.m. ET, to discuss the results. Interested parties can access the conference call via webcast, available in the investors section of the company&#8217;s website at\u00a0https:\/\/ir.syrahealth.com\/presentations\/q4-and-full-year-2024-earnings-call. Investors who would like &hellip; Continue reading \"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-04T13:58:20+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results","datePublished":"2025-03-04T13:58:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"},"wordCount":282,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/","name":"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.jpg","datePublished":"2025-03-04T13:58:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1834874\/Syra_Health_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/syra-health-to-discuss-fourth-quarter-and-full-year-2024-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821342","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=821342"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/821342\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=821342"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=821342"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=821342"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}